跳至主要内容
临床试验/NCT00689455
NCT00689455已完成不适用

Regional Observatory on Metabolic Syndrome in Italy- LAZIO

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,574 人开始时间: 2007年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,574
试验地点
1
主要终点
Prevalence of Metabolic Syndrome in Primary Care Population.

研究概览

简要总结

The aim of the study, is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.

研究设计

研究类型
Observational
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • lipid profile in the last year
  • Signed informed consent

排除标准

  • Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study
  • Pregnancy or breast feeding
  • Subject who are unwilling or unable to provide the informed consent

结局指标

主要结局

Prevalence of Metabolic Syndrome in Primary Care Population.

时间窗: At Visit

次要结局

  • Concomitant presence of other CV risk factors.(At Visit)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验